Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VEGF Protein (AA 27-191) (His tag)

This Recombinant VEGF protein is produced in HEK-293 Cells. There is 1 publication available.
Catalog No. ABIN2181905

Quick Overview for VEGF Protein (AA 27-191) (His tag) (ABIN2181905)

Target

See all VEGF Proteins
VEGF (Vascular Endothelial Growth Factor (VEGF))

Protein Type

Recombinant

Biological Activity

Active

Origin

  • 11
  • 6
  • 1
  • 1
Human

Source

  • 6
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
HEK-293 Cells

Purity

>90 % as determined by SDS-PAGE.
  • Protein Characteristics

    AA 27-191

    Purification tag / Conjugate

    This VEGF protein is labelled with His tag.

    Sequence

    AA 27-191

    Characteristics

    This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 20 kDa (monomer). As a result of glycosylation, the protein migrates as 25 kDa (monomer) under reducing (R) condition, and 43-50 kDa (homodimer) under non-reducing (NR) condition (SDS-PAGE).

    Sterility

    0.22 μm filtered

    Endotoxin Level

    Less than 1.0 EU per μg by the LAL method.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    PBS, pH 7.4

    Handling Advice

    Please avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    No activity loss was observed after storage at: In lyophilized state for 1 year (4 °C), After reconstitution under sterile conditions for 3 months (-70 °C).
  • Kerros, Tripathi, Zha, Mehrens, Sergeeva, Philips, Qiao, Peters, Katayama, Sukhumalchandra, Ruisaard, Perakis, St John, Lu, Mittendorf, Clise-Dwyer, Herrmann, Alatrash, Toniatti, Hanash, Ma, Molldrem: "Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells." in: The Journal of biological chemistry, Vol. 292, Issue 24, pp. 10295-10305, (2017) (PubMed).

  • Target

    VEGF (Vascular Endothelial Growth Factor (VEGF))

    Alternative Name

    VEGF

    Background

    VEGF165 is the most abundant splice variant of VEGF-A. VEGF165 is produced by a number of cells including endothelial cells, macrophages and T cells. VEGF165 is involved in angiogenesis, vascular endothelial cell survival, growth, migration and vascular permeability. VEGF gene expression is induced by hypoxia, inflammatory cytokines and oncogenes. VEGF165 binds to heparan sulfate and is retained on the cell surface and in the extracellular matrix. VEGF165 binds to the receptor tyrosine kinases, VEGFR1 and VEGFR2. VEGF165 is the only splice variant that binds to co-receptors NRP-1 and NRP-2 that function to enhance VEGFR2 signaling. Binding of VEGF165 to VEGFR1 and VEGFR2 leads to activation of the PI3K/AKT, p38 MAPK, FAK and paxillin. VEGF plays a key role in tumor angiogenesis in many cancers.

    Molecular Weight

    21.1 kDa

    NCBI Accession

    NP_001165097
You are here:
Chat with us!